161 related articles for article (PubMed ID: 2331854)
21. In-vitro activity of PD 117558, a new quinolone against bacterial isolates from cancer patients.
Rolston KV; LeBlanc B; Gooch G; Ho DH; Bodey GP
J Antimicrob Chemother; 1989 Mar; 23(3):363-71. PubMed ID: 2732120
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
Dubois J; Joly JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
[TBL] [Abstract][Full Text] [Related]
23. Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone.
Visser MR; Rozenberg-Arska M; Beumer H; Hoepelman IM; Verhoef J
Antimicrob Agents Chemother; 1991 May; 35(5):858-68. PubMed ID: 1854167
[TBL] [Abstract][Full Text] [Related]
24. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
Hoban D; Grabowski M; Koss J; Weselowski V
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial effects of lomefloxacin in vitro.
Chambers ST; Peddie BA; Robson RA; Begg EJ; Boswell DR
J Antimicrob Chemother; 1991 Apr; 27(4):481-9. PubMed ID: 1856127
[TBL] [Abstract][Full Text] [Related]
26. In-vitro assessment of lomefloxacin (SC-47111)--a new quinolone derivative.
Finch R; Martin J; Pilkington R
J Antimicrob Chemother; 1988 Dec; 22(6):881-4. PubMed ID: 3243735
[TBL] [Abstract][Full Text] [Related]
27. In vitro evaluation of lomefloxacin activity in Colombia.
Trujillo H; Mejia GI; Castrillon L; Gomez C
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of lomefloxacin (SC 47111 or NY-198) against Chlamydia trachomatis strains.
Segreti J; Kessler HA; Kapell K; Trenholme GM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):87S-88S. PubMed ID: 2791503
[TBL] [Abstract][Full Text] [Related]
29. Quinolone activity against anaerobes.
Appelbaum PC
Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
[TBL] [Abstract][Full Text] [Related]
30. In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea.
Segreti J; Nelson JA; Goodman LJ; Kaplan RL; Trenholme GM
Antimicrob Agents Chemother; 1989 Aug; 33(8):1385-7. PubMed ID: 2802563
[TBL] [Abstract][Full Text] [Related]
31. Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity.
Jones RN
Am J Med; 1992 Apr; 92(4A):52S-57S. PubMed ID: 1316072
[TBL] [Abstract][Full Text] [Related]
32. Overview of the fluoroquinolone antibiotics.
Just PM
Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
[TBL] [Abstract][Full Text] [Related]
33. Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin.
Edwards R; Kanematsu M; Greenwood D
J Antimicrob Chemother; 1988 Dec; 22(6):885-90. PubMed ID: 3243736
[TBL] [Abstract][Full Text] [Related]
34. Lomefloxacin disc susceptibility criteria--a reappraisal.
Smith JM; Hashmi ZS
J Antimicrob Chemother; 1990 Jul; 26(1):152-3. PubMed ID: 2211438
[No Abstract] [Full Text] [Related]
35. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
Stratton CW; Weeks LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):29S-34S. PubMed ID: 2791495
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of lomefloxacin as compared with ciprofloxacin.
Inderlied CB; Lancero MG; Bermudez LM; Young LS
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):17S-20S. PubMed ID: 2791493
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility pattern of bacterial isolates to lomefloxacin.
Lalitha MK; Nisha AK; Bhattacharya SS; Ramamoorthy U; Lal HM
Indian J Med Res; 1990 May; 91():182-4. PubMed ID: 2397938
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Drugs Exp Clin Res; 1992; 18(8):311-7. PubMed ID: 1338041
[TBL] [Abstract][Full Text] [Related]
39. BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000).
Gordon KA; Pfaller MA; Jones RN;
J Antimicrob Chemother; 2002 May; 49(5):851-5. PubMed ID: 12003983
[TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
Rolston KV; LeBlanc B; Ho DH; Bodey GP
J Antimicrob Chemother; 1990 Jul; 26(1):39-44. PubMed ID: 2211445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
